Search Results - "Peterson, Kendell"

Loss of ANCO1 Expression Regulates Chromatin Accessibility and Drives Progression of Early-Stage Triple-Negative Breast Cancer by Yuan, Meng, Barefoot, Megan E, Peterson, Kendell, Campbell, Moray J, Blancato, Jan K, Chen, Manjing, Schmidt, Marcel O, Kiliti, Amber J, Fang, Hong-Bin, Wellstein, Anton, Riegel, Anna T, Sharif, Ghada M

“…Mutations in the gene ankyrin repeat domain containing 11 ( / ) play a role in neurodegenerative disorders, and its loss of heterozygosity and low expression…”
Get full text

Non-enzymatic glycoxidation linked with nutrition enhances the tumorigenic capacity of prostate cancer epithelia through AGE mediated activation of RAGE in cancer associated fibroblasts by Krisanits, Bradley A., Woods, Pamela, Nogueira, Lourdes M., Woolfork, Demarcus D., Lloyd, Courtney E., Baldwin, Andrew, Frye, Callan C., Peterson, Kendell D., Cosh, Sean D., Guo, Qi-Jin, Spruill, Laura S., Lilly, Michael B., Helke, Kristi, Li, Hong, Hanna, George S., Hamann, Mark T., Thomas, Courtney, Ahmed, Mahtabuddin, Gooz, Monika B., Findlay, Victoria J., Turner, David P.

“…•Nutrition associated glycoxidation promotes aggressive prostate tumor growth.•AGEs, the final product of glycoxidation were a key pro-tumorigenic…”
Get full text

Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma by Ochoa-Rios, Shaaron, Blaschke, Calvin R K, Wang, Mengjun, Peterson, Kendell D, DelaCourt, Andrew, Grauzam, Stéphane Elie, Lewin, David, Angel, Peggi, Roberts, Lewis R, Drake, Richard, Mehta, Anand S

“…There is an urgent need for the identification of reliable prognostic biomarkers for patients with intrahepatic cholangiocarcinoma (iCCA) and alterations in…”
Get full text

MDB-107. MINNELIDE, A PROMISING COMPOUND FOR THE TREATMENT OF HIGH-RISK MEDULLOBLASTOMA by Blanco, Jezabel Rodriguez, Salvador, April, Sahani, Pritika, Kliebe, Valentin, Peterson, Kendell, Turos, Maria

“…Despite the overall good outcome of children with medulloblastoma (MB), a subset faces the challenge of highly aggressive metastatic tumors. The poor prognosis…”
Get full text

Mechanistic insights into medulloblastoma relapse by Peterson, Kendell, Turos-Cabal, Maria, Salvador, April D., Palomo-Caturla, Isabel, Howell, Ashley J., Vieira, Megan E., Greiner, Sean M., Barnoud, Thibaut, Rodriguez-Blanco, Jezabel

“…Pediatric brain tumors are the leading cause of cancer-related deaths in children, with medulloblastoma (MB) being the most common type. A better understanding…”
Get full text

Triptolide and its prodrug Minnelide target high-risk MYC-amplified medulloblastoma in preclinical models by Rodriguez-Blanco, Jezabel, Salvador, April D, Suter, Robert K, Swiderska-Syn, Marzena, Palomo-Caturla, Isabel, Kliebe, Valentin, Shahani, Pritika, Peterson, Kendell, Turos-Cabal, Maria, Vieira, Megan E, Wynn, Daniel T, Howell, Ashley J, Yang, Fan, Ban, Yuguang, McCrea, Heather J, Zindy, Frederique, Danis, Etienne, Vibhakar, Rajeev, Jermakowicz, Anna, Martin, Vanesa, Coss, Christopher C, Harris, Brent T, de Cubas, Aguirre, Chen, X Steven, Barnoud, Thibaut, Roussel, Martine F, Ayad, Nagi G, Robbins, David J

“…Most children with medulloblastoma (MB) achieve remission, but some face very aggressive metastatic tumors. Their dismal outcome highlights the critical need…”
Get full text